Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2026 Mar 24.
Published before final editing as: European J Org Chem. 2026 Mar 6:e70356. doi: 10.1002/ejoc.70356

EDA Complex–Mediated C(sp3)–H Cross-Dehydrogenative Coupling Enables Synthesis of Noncanonical α,β-Diamino Acids

Krishnakumar Sachidanandan 1, Cole Stenftenagel 1, Athul Joshy 1, Alexander M Cluff 1, Sébastien Laulhé 1
PMCID: PMC13008348  NIHMSID: NIHMS2155251  PMID: 41878725

Abstract

Nonproteinogenic α,β-diamino acids are key motifs in bioactive compounds. We report a photoinduced cross-dehydrogenative coupling (CDC) of N-arylglycine derivatives with amides. This reaction proceeds via an electron donor–acceptor (EDA) complex that enables regioselective C(sp3)–C(sp3) cross-coupling, providing access to non-canonical α,β-diamino acids from simple precursors.

Keywords: α,β-diamino acid; aryl radical; cross-dehydrogenative coupling; electron donor–acceptor complex

1 |. Introduction

Noncanonical amino acids (nCAAs) have emerged as pivotal structural motifs in drug discovery, due to their enhanced versatility compared to their natural counterparts [1–3]. This has accelerated their integration into medicinal chemistry libraries for the development of novel therapeutics [4–8]. In particular, α,β-diamino acid containing small molecules have garnered sustained attention due to their diverse pharmacological profiles [9, 10]. Notable examples include alanosine, which exhibits antitumor activity [11, 12], and roxifiban, a synthetic agent developed for cardiovascular disorders (Scheme 1) [13–16]. Furthermore, α,β-diamino acids serve as valuable precursors for the synthesis of 1,2-diamines, which find broad application as chiral auxiliaries and as ligands in asymmetric metal catalysis [17].

SCHEME 1 |.

SCHEME 1 |

Drugs motifs containing α,β-diamino acid derivatives.

In recent years, there has been increased interest in accessing α,β-diamino acid scaffolds using imines and oximes as reactive coupling partners [18]. Among these methods, only two radical-based transformations have been developed, and they require the use of oxime derivatives [19, 20]. These examples proceed via (i) photo-catalytic decarboxylation (Scheme 2A) [19] and (ii) borane-mediated decarbonylation (Scheme 2B) [20].

SCHEME 2 |.

SCHEME 2 |

(A) Previous decarboxylative reaction with oximes. (B) Previous α-aminoacyl tellurides reaction with oximes. (C) Our cross-dehydrogenative coupling approach.

Unfortunately, these strategies suffer from limited versatility given that they are inherently restricted to noncommercially available oxime-based systems, reliant on pre-functionalized radical precursors, and in one case they require highly flammable Et3B (auto ignites at −20°C in air). In contrast, a more straightforward approach would involve a cross-dehydrogenative coupling strategy [21], whereby two C(sp3)–H bonds are simultaneously activated enabling direct bond formation between both species. This eliminates the need for prefunctionalized auxiliaries and mitigates associated synthetic drawbacks such as accessing the oxime intermediates.

Electron donor–acceptor (EDA) complexes have prompted considerable attention over the past decade, unlocking a broad spectrum of molecular transformations that were once confined to metal-catalyzed or otherwise intricate systems [22–26]. Our group has actively contributed to this growing toolbox, developing versatile methodologies that emphasize the operational simplicity and environmentally benign nature of aryl halide-based EDA strategies [27–29]. Electron-deficient aryl halides proved to be particularly versatile as hydrogen-atom transfer (HAT) agents in cross-dehydrogenative processes as we demonstrated previously in our work [27], and elegantly re-emphasized recently by Gevorgyan and Wang [30–32]. Building on these advances, we report a photoinduced synthesis of noncanonical α,β-diamino acids via EDA complex–mediated cross-dehydrogenative coupling (Scheme 2C).

2 |. Results and Discussion

Optimization studies commenced using N-phenyl-2-(phenylamino)acetamide (1) as the amino acid derivative and N,N-dimethylformamide (2) as the alkane coupling partner to furnish the target product, 3-(N-methylformamido)-N-phenyl-2(phenylamino)propanamide (3a) (Table 1). Under optimal conditions, employing 1-iodo-4-(trifluoromethyl)benzene (Ar-1) and Cs2CO3, afforded product 3a in a commendable 52% yield (Entry 1).

TABLE 1 |.

Optimization study.

graphic file with name nihms-2155251-t0001.jpg

However, altering the solvent system from neat DMF to a 1:1 mixture of DMF and MeCN resulted in a significant drop of yield to 19% (Entry 2). Modifying the electronics of the aryl halide to electron-rich or electronically neutral variants proved detrimental to the reaction efficiency (Entries 3 and 4), presumably due to a less efficient EDA complex formation between the aryl iodide and the glycine derivative. Substituting Cs2CO3 with either K2CO3 or Et3N led to a marked decrease in product yield, affording 3a in only 14% and 13%, respectively (Entries 5 and 6). Altering the irradiation wavelength to lower-energy 440 nm also proved detrimental, resulting in a reduced yield of 22% (Entry 7). Furthermore, control experiments in the absence of light yielded no detectable product (Entry 8) (see Supporting Information for detailed data, page SI-5).

Next, we turned our attention to exploring the substrate scope of this transformation, beginning with variations in the alkyl motifs while retaining compound 1 as the glycine-derived scaffold (Scheme 3). Both dimethylformamide and dimethylacetamide were successfully coupled under the optimized conditions, affording the desired α,β-diamino acid derivatives 3a and 3b in 50% yield each. Similarly, the formamide and acetamide analogs of the N,N-dimethyl system were well tolerated, delivering products 3c and 3d in 56% and 52% yields, respectively. N,N-dimethylpropionamide was successfully coupled with substrate 1, affording the corresponding α,β-diamino acid 3e in 44% yield. Notably, the transformation also tolerated a cyclic amide, 1-methylpyrrolidin-2-one, delivering the product 3f as a mixture of regioisomers in 55% yield, with the major product favoring the activation of the methylene moiety over the methyl group. Importantly, Boc-protected amines were tolerated and afforded product 3g in synthetically useful 52% yield. This result highlights the method’s compatibility with carbamate functionalities, expanding its utility for further functionalizations.

SCHEME 3 |.

SCHEME 3 |

Substrate scope. * 1.0 mmol.

The scope of the transformation was further explored using various glycine derivatives, wherein N,N-dimethylacetamide served as the alkylating motif. Initial efforts focused on substrates bearing aromatic substitutions on the amide side chain of the amino acid. Meta-substituted electron withdrawing (-CF3) and halogenated (-Br) derivatives were tolerated in forming products 3h and 3i both in 40% yields. Electron-rich aromatic substitutions also afforded the desired products. Specifically, the tri-methoxy-phenyl derivative furnished product 3j in 50% yield, while the trimethylsubstituted analog afforded 3k in low 33% yield. Aromatic substitutions on the amine side of the glycine scaffold were further investigated using meta-substituted electron-withdrawing groups. The trifluoromethyl derivative yielded product 3l in 25%, while the brominated analog afforded 3m in 51% yield. The electron-donating para-methoxy group delivered the desired product 3n in 35% yield, demonstrating compatibility with deprotection.

A diverse set of protecting groups were evaluated on the amino acid scaffold, beginning with N,N-dimethylamide derivatives. Both N,N-dimethylacetamide (DMA) and 2,2,2-trifluoro-N,N-dimethylacetamide were well tolerated under the reaction conditions, affording products 3o and 3p in 51% and 18% yield, respectively. These results indicate that highly electron-deficient amides are not effective coupling partners for this transformation. The ethyl ester derivative of aryl glycine was employed to couple N,N-diethylformamide and N,N-diethylacetamide, affording products 3q (43%) and 3r (30%). Both tert-butyl and phenyl ester derivatives of aryl glycine also furnished the corresponding DMA-coupled products 3s (20%) and 3t (44%). Finally, glycine esters bearing bioactive motifs, menthol and cholesterol, were evaluated in the reaction with DMA, delivering cross-coupled products 3u and 3v in moderate yields of 37% and 40%, respectively. In comparison to previously reported ethereal couplings [27], yields reported in this substrate scope may be lower due to stronger α-C–H bonds [33] in amide systems. Indeed, remaining amino acid starting material is found unreacted in all these reactions.

To probe the involvement of radical intermediates in the transformation, we conducted a series of radical trapping experiments under standard reaction conditions. The additives, TEMPO, 1,1-diphenylethylene (1,1-DPE), and butylated hydroxytoluene (BHT) were introduced individually in separate reactions (Scheme 4). Formation of the desired product was completely suppressed in all three conditions, suggesting the involvement of a radical-based mechanism. Additionally, both TEMPO and 1,1-DPE effectively trapped multiple radical intermediates, including the DMF- and aryl-derived radicals (see Supporting Information for detailed HRMS and GC–MS data, page SI-30).

SCHEME 4 |.

SCHEME 4 |

Mechanistic Studies. (A) Radical trapping studies. (B) UV-Vis studies.

To investigate the possibility of photoactive aggregate formation, UV-Vis absorption studies were conducted under various combinations [34, 35]. Notably, the mixture of 1 and Ar-1 exhibited a pronounced increase in absorption intensity relative to the individual components, suggesting the formation of a ground–state interaction. Upon addition of Cs2CO3, a further enhancement in absorption was observed, consistent with base-mediated stabilization or deprotonation effects that may facilitate complexation [27]. These observations collectively support the formation of an EDA complex between 1 and Ar-1, which likely plays a key role in initiating the photochemical transformation.

Based on experimental results and literature precedent [27, 36, 37], we propose the following mechanism for the transformation. The arylglycine derivative 1 and electron-deficient aryl iodide Ar-1 form a photoactive EDA complex that undergoes a single electron transfer (SET), generating the amino radical cation A and aryl radical anion B. Subsequent deprotonation of A furnishes the persistent α-amino radical E. Concurrently, fragmentation of B via iodide extrusion yields the aryl radical C, which engages in a site-selective HAT process with amide reagent 2 to produce the corresponding N-ortho radical G.

Finally, radical–radical coupling between E and G delivers the desired C(sp3)–C(sp3) cross-coupled product 3a (Scheme 5).

SCHEME 5 |.

SCHEME 5 |

Proposed mechanism.

3 |. Conclusion

In summary, we have opened a new avenue to access α,β-diamino acids beyond traditional oxime-based strategies and their limitations. Our EDA-mediated cross-dehydrogenative coupling strategy enables the direct C(sp3)–H functionalization of amides and N-phenyl glycine derivatives. Ongoing efforts in our laboratory are focused on expanding the scope to include benzylic and heteroatom-containing alkyl motifs, while simultaneously improving overall reaction performance. These investigations aim to broaden the applicability of EDA approaches as robust platforms for C(sp3)–C(sp3) bond formation.

Supplementary Material

Supplemental Material

Additional supporting information can be found online in the Supporting Information section. The authors have cited additional references within the Supporting Information [38–40]. Supporting Table S1: 1HNMR yields using 1,2-dibromoethane as internal standard.

Acknowledgments

Research reported in this publication was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number R35GM151227. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Funding

This study was supported by National Institute of General Medical Sciences (R35GM151227).

Footnotes

Conflicts of Interest

The authors declare no conflicts of interest.

Data Availability Statement

The data that supports the findings of this study are available in the supplementary material of this article.

References

  • 1.Hickey JL, Sindhikara D, Zultanski SL, and Schultz DM, “Beyond 20 in the 21st Century: Prospects and Challenges of Non-Canonical Amino Acids in Peptide Drug Discovery,” ACS Medicinal Chemistry Letters 14 (2023): 557–565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Blaskovich MA, “Unusual Amino Acids in Medicinal Chemistry,” Journal of Medicinal Chemistry 59 (2016): 10807–10836. [DOI] [PubMed] [Google Scholar]
  • 3.Li X, Craven TW, and Levine PM, “Cyclic Peptide Screening Methods for Preclinical Drug Discovery,” Journal of Medicinal Chemistry 65 (2022): 11913–11926. [DOI] [PubMed] [Google Scholar]
  • 4.Wang C, Qi R, Wang R, and Xu Z, “Photoinduced C(sp 3)–H Functionalization of Glycine Derivatives: Preparation of Unnatural α-Amino Acids and Late-Stage Modification of Peptides,” Accounts of Chemical Research 56 (2023): 2110–2125. [DOI] [PubMed] [Google Scholar]
  • 5.Aguilar Troyano FJ, Merkens K, Anwar K, and Gómez-Suárez A, “Radical-Based Synthesis and Modification of Amino Acids,” Angewandte Chemie International Edition 60 (2021): 1098–1115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Reetz MT, “New Approaches to the Used of Amino Acids as Chiral Building Blocks in Organic Synthesis,” Angewandte Chemie International Edition 30 (1991): 1531–1546. [Google Scholar]
  • 7.Singh P, Samanta K, Das SK, and Panda G, “Amino Acid Chirons: A Tool for Asymmetric Synthesis of Heterocycles,” Organic & Biomolecular Chemistry 12 (2014): 6297–6339. [DOI] [PubMed] [Google Scholar]
  • 8.Walsh CT, O’Brien RV, and Khosla C, “Nonproteogenic Amino Acid Building Blocks for Nonribosomal Peptide and Hybrid Polyketide Scaffolds,” Angewandte Chemie International Edition 52 (2013): 7098–7124. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Viso A, Fernández de la Pradilla R, García A, and Flores A, “α,β-Diamino Acids: Biological Significance and Synthetic Approaches,” Chemical Reviews 105 (2005): 3167–3196. [DOI] [PubMed] [Google Scholar]
  • 10.Viso A, Fernández de la Pradilla R, Tortosa M, García A, and Flores A, “Update 1 of: α,β-Diamino Acids: Biological Significance and Synthetic Approaches,” Chemical Reviews 111 (2011): PR1–PR42. [DOI] [PubMed] [Google Scholar]
  • 11.Goldsmith MA, Ohnuma T, Spigelman M, Greenspan EM, and Holland JF, “Phase I Study of L-Alanosine (NSC 15353),” Cancer 51 (1983): 378–380. [DOI] [PubMed] [Google Scholar]
  • 12.Singh SX, Yang R, Roso K, et al. , “Purine Synthesis Inhibitor L-Alanosine Impairs Mitochondrial Function and Stemness of Brain Tumor Initiating Cells,” Biomedicines 10 (2022): 751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Xue C-B, Wityak J, Sielecki TM, et al. , “Discovery of an Orally Active Series of Isoxazoline Glycoprotein IIb/IIIa Antagonists,” Journal of Medicinal Chemistry 40 (1997): 2064. [DOI] [PubMed] [Google Scholar]
  • 14.Serebruany VL, Malinin AI, O’Connor CM, and Gurbel PA, “Effects of Roxifiban on Platelet Aggregation and Major Receptor Expression in Patients with Coronary Artery Disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy),” American Heart Journal 146 (2003): 91. [DOI] [PubMed] [Google Scholar]
  • 15.Murphy J, Wright RS, Gussak I, et al. , “The Use of Roxifiban (DMP754), a Novel Oral Platelet Glycoprotein IIb/IIIa Receptor Inhibitor, in Patients with Stable Coronary Artery Disease,” American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions 3 (2003): 101. [DOI] [PubMed] [Google Scholar]
  • 16.Mousa SA, Bozarth JM, Naik UP, and Slee A, “Platelet GPIIb/IIIa Binding Characteristics of Small Molecule RGD Mimetic: Distinct Binding Profile for Roxifiban,” British Journal of Pharmacology 133 (2001): 331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Lucet D, Le Gall T, and Mioskowski C, “The Chemistry of Vicinal Diamines,” Angewandte Chemie International Edition in English 37 (1998): 2580–2627. [DOI] [PubMed] [Google Scholar]
  • 18.Arrayás RG and Carretero JC, “Catalytic Asymmetric Direct Mannich Reaction: A Powerful Tool for the Synthesis of α,β-Diamino Acids,” Chemical Society Reviews 38 (2009): 1940–1948. [DOI] [PubMed] [Google Scholar]
  • 19.Nagatomo M, Nishiyama H, Fujino H, and Inoue M, “Decarbonylative Radical Coupling of α-Aminoacyl Tellurides: Single-Step Preparation of γ-Amino and α,β-Diamino Acids and Rapid Synthesis of Gabapentin and Manzacidin A,” Angewandte Chemie International Edition 54 (2015): 1537–1541. [DOI] [PubMed] [Google Scholar]
  • 20.Wu G, Wang J, Liu C, et al. , “Transition Metal-Free, Visible-Light-Mediated Construction of α,β-Diamino Esters via Decarboxylative Radical Addition at Room Temperature,” Organic Chemistry Frontiers : an International Journal of Organic Chemistry 6 (2019): 2245–2249. [Google Scholar]
  • 21.Tian T, Li Z, and Li C-J, “Cross-Dehydrogenative Coupling: a Sustainable Reaction for C-C Bond Formations,” Green Chemistry 23 (2021): 6789–6862. [Google Scholar]
  • 22.de Pedro Beato E, Spinnato D, Zhou W, and Melchiorre P, “A General Organocatalytic System for Electron Donor–Acceptor Complex Photoactivation and Its Use in Radical Processes,” Journal of the American Chemical Society 143 (2021): 12304–12314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Crisenza G, Mazzarella D, and Melchiorre P, “Synthetic Methods Driven by the Photoactivity of Electron Donor–Acceptor Complexes,” Journal of the American Chemical Society 142 (2020): 5461–5476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Tian YM, Hofmann E, Silva W, et al. , “Enforced Electronic-Donor-Acceptor Complex Formation in Water for Photochemical Cross-Coupling,” Angewandte Chemie International Edition 62 (2023): e202218775. [DOI] [PubMed] [Google Scholar]
  • 25.McClain EJ, Monos TM, Mori M, Beatty JW, and Stephenson CR, “Design and Implementation of a Catalytic Electron Donor–Acceptor Complex Platform for Radical Trifluoromethylation and Alkylation,” ACS Catalysis 10 (2020): 12636–12641. [Google Scholar]
  • 26.Volkov AA, Bugaenko DI, and Karchava AV, “Transition Metal and Photocatalyst Free Arylation via Photoexcitable Electron Donor Acceptor Complexes:Mediation and Catalysis,” ChemCatChem 16 (2024): e202301526. [Google Scholar]
  • 27.Sachidanandan K, Stenftenagel C, Cluff AM, et al. , “Sequential EDA/HAT Enables C(sp3)–C(sp3) Cross-Dehydrogenative Coupling: Accessing Non-Canonical Amino Acids with Quaternary Carbon Centers from Activated and Non-Activated Alkanes,” Organic Letters 27 (2025): 5619–5624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Pan L, Deckert MM, Cooke MV, Bleeke AR, and Laulhé S, “Solvent Anions Enable Photoinduced Borylation and Phosphonation of Aryl Halides via EDA Complexes,” Organic Letters 24 (2022): 6466–6471. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Pan L, Cooke MV, Spencer A, and Laulhé S, “Dimsyl Anion Enables Visible-Light-Promoted Charge Transfer in Cross-Coupling Reactions of Aryl Halides,” Advanced Synthesis & Catalysis 364 (2022): 420–425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wagulde S, Rai P, and Gevorgyan V, “Nickel-Catalyzed Cross-Dehydrogenative Coupling of Aldehydes and Alkenes toward Skipped Enones,” Journal of the American Chemical Society 147 (2025): 34211–34217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Dang X, Zhang C, Shang J, et al. , “Electron Donor–acceptor Complex of Aryl Sulfonium Salt Enabling Hydrogen/Halogen Atom Transfer: C(sp 3)–H Alkylation of Glycine Derivatives and Late-Stage Modification of Peptides,” Chemical Communications 61 (2025): 11279–11282. [DOI] [PubMed] [Google Scholar]
  • 32.Zhou Q, Zhang Y, Shang J, et al. , “Photoinduced and Copper-Catalyzed Asymmetric Alkylation of Glycine Derivatives via a Synergistic Electron/Atom Transfer Process,” ACS Catalysis 15 (2025): 17504–17512. [Google Scholar]
  • 33.Salamone M, Milan M, DiLabio GA, and Bietti M, “Absolute Rate Constants for Hydrogen Atom Transfer from Tertiary Amides to the Cumyloxyl Radical: Evaluating the Role of Stereoelectronic Effects,” The Journal of Organic Chemistry 79 (2014): 7179–7184. [DOI] [PubMed] [Google Scholar]
  • 34.Wortman AK and Stephenson CR, “EDA Photochemistry: Mechanistic Investigations and Future Opportunities,” Chem 9 (2023): 2390–2415. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lalevee J, Fouassier J, Blanchard N, and Ingold KU, “Reaction between Aminoalkyl Radicals and Akyl Halides: Dehalogenation by Electron Transfer?,” Chemical Physics Letters 511 (2011): 156–158. [Google Scholar]
  • 36.Wang C, Qi R, Xue H, et al. , “Visible-Light-Promoted C(sp3)−H Alkylation by Intermolecular Charge Transfer: Preparation of Unnatural α-Amino Acids and Late-Stage Modification of Peptides,” Angewandte Chemie International Edition 132 (2020): 7531–7536. [DOI] [PubMed] [Google Scholar]
  • 37.Xie X, Qiao K, Shao B.-r., Jiang W, and Shi L, “Visible-Light-Promoted Radical Cross-Dehydrogenative Coupling of C(sp3)–H/C(sp3)–H and C(sp3)–H/C(sp2)–H via Intermolecular HAT,” Organic Letters 25 (2023): 4264–4269. [DOI] [PubMed] [Google Scholar]
  • 38.Murugesan K, Donabauer K, Narobe R, Derdau V, Bauer A, and König B, “Photoredox-Catalyzed Site-Selective Generation of Carbanions from C(sp3)–H Bonds in Amines,” ACS Catalysis 12 (2022): 3974–3984. [Google Scholar]
  • 39.Kalluraya B, Aamir S, and Shabaraya A, “Regioselective Reaction: Synthesis, Characterization and Pharmacological Activity of Some New Mannich and Schiff Bases Containing Sydnone,” European Journal of Medicinal Chemistry 54 (2012): 597–604. [DOI] [PubMed] [Google Scholar]
  • 40.Zhi H, Ung SPM, Liu Y, Zhao L, and Li CJ, “Phosphorylation of Glycine Derivatives via Copper(I)-Catalyzed CSp3−H Bond Functionalization,” Advanced Synthesis & Catalysis 358 (2016): 2553–2557. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Material

Data Availability Statement

The data that supports the findings of this study are available in the supplementary material of this article.

RESOURCES